Barclays analyst issues EQUAL-WEIGHT recommendation for OTIS on October 2, 2024 05:37AM ET. The previous analyst recommendation was Equal-Weight.OTIS was trading at $103.77 at issue of the analyst...
Barclays analyst issues OVERWEIGHT recommendation for PNR on October 2, 2024 05:38AM ET. The previous analyst recommendation was Overweight.PNR was trading at $96.81 at issue of the analyst...
Barclays analyst issues OVERWEIGHT recommendation for MMM on October 2, 2024 05:38AM ET. The previous analyst recommendation was Overweight.MMM was trading at $137.06 at issue of the analyst...
Barclays analyst issues OVERWEIGHT recommendation for NVT on October 2, 2024 05:37AM ET. The previous analyst recommendation was Overweight.NVT was trading at $68.81 at issue of the analyst...
Barclays analyst issues OVERWEIGHT recommendation for RRX on October 2, 2024 05:38AM ET. The previous analyst recommendation was Overweight.RRX was trading at $163.72 at issue of the analyst...
Barclays analyst issues OVERWEIGHT recommendation for TT on October 2, 2024 05:39AM ET. The previous analyst recommendation was Overweight.TT was trading at $386.63 at issue of the analyst...
Hovde Group analyst issues OUTPERFORM recommendation for CARE on October 2, 2024 05:40AM ET. CARE was trading at $17.04 at issue of the analyst recommendation.The overall analyst consensus...
Barclays analyst issues UNDERWEIGHT recommendation for RVLV on October 2, 2024 05:44AM ET. The previous analyst recommendation was Underweight.RVLV was trading at $23.7 at issue of the analyst...
Barclays analyst issues EQUAL-WEIGHT recommendation for SMCI on October 2, 2024 05:45AM ET. The previous analyst recommendation was Equal-Weight.SMCI was trading at $40.55 at issue of the analyst...
Barclays analyst issues OVERWEIGHT recommendation for MELI on October 2, 2024 05:42AM ET. The previous analyst recommendation was Overweight.MELI was trading at $2066.12 at issue of the analyst...